Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (131-140 of 238) with videos related to

Pageof 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND StudyPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.
Blood|October 26, 2016
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemiaSarah K Tasian, David T Teachey, Yong Li, et al.
Critical Care Medicine|September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic LeukemiaJulie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.
Blood Advances|November 20, 2024
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapyBarbara D Friedes, Amanda M DiNofia, Emma Iannone, et al.
Blood|October 11, 2007
Targeting Notch signaling in autoimmune and lymphoproliferative diseaseDavid T Teachey, Alix E Seif, Valerie I Brown, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 PandemicVeronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.
Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Pageof 24

Showing results (131-140 of 238) with videos related to

Sort By:
Pageof 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND StudyPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.
Blood|October 26, 2016
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemiaSarah K Tasian, David T Teachey, Yong Li, et al.
Critical Care Medicine|September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic LeukemiaJulie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.
Blood Advances|November 20, 2024
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapyBarbara D Friedes, Amanda M DiNofia, Emma Iannone, et al.
Blood|October 11, 2007
Targeting Notch signaling in autoimmune and lymphoproliferative diseaseDavid T Teachey, Alix E Seif, Valerie I Brown, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 PandemicVeronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.
Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Pageof 24